Leading the Way in Life Science Technologies

GEN Exclusives

More »

Feature Articles

More »

For full access to this article login to GEN Select now.

March 15, 2008 (Vol. 28, No. 6)

Paucity of Biopharma Approvals Raises Alarm

Lower Numbers, Novelty, and Economic Impact Indicate Problems

  • FDA pharmaceutical approvals in recent years, particularly in 2007, have noticeably decreased. Typically, coverage of declining FDA approvals has concentrated on pharmaceuticals in general or those regulated as drugs. This article reviews 2006 and 2007 approvals of new biopharmaceutical treatments and notes some disturbing trends. These include fewer drugs given ...

Not registered yet? Please fill out the form below and enjoy complimentary access to this and an exclusive collection of premium content and personalization features as a GEN Select insider. Learn More.

Get GEN Select Access Now

    • Do not put any letters or characters here if you are not a spy program.